Hematologic Malignancies

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

Terminated
  • Hematologic Malignancies
  • Aurora, Colorado
  • +16 more
Apr 29, 2022

Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Hematologic Malignancies, Hypoproliferative Thrombocytopenia Trial in United States (Mirasol platelets (MIR PLTs), Reference

Terminated
  • Hematologic Malignancies
  • Hypoproliferative Thrombocytopenia
  • Mirasol platelets (MIR PLTs)
  • Reference platelets (REF PLTs)
  • Washington, District of Columbia
  • +9 more
Jul 28, 2021

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Tumors, Hematologic Malignancies Trial in Worldwide (Atezolizumab)

Completed
  • Tumors
  • Hematologic Malignancies
  • Scottsdale, Arizona
  • +20 more
Dec 10, 2018

Hematologic Malignancies Trial in Baltimore, New York, Houston (IPI-493)

Terminated
  • Hematologic Malignancies
  • Baltimore, Maryland
  • +2 more
Apr 14, 2015